Insider Selling: 111 (NASDAQ:YI) Director Sells 49,920 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 49,920 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $0.23, for a total value of $11,481.60. Following the completion of the sale, the director directly owned 539,462 shares of the company’s stock, valued at approximately $124,076.26. This represents a 8.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Monday, June 15th, Yang Luke Chen sold 44,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total value of $10,120.00.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $388.80.

111 Stock Performance

NASDAQ:YI opened at $4.57 on Tuesday. The firm has a market cap of $40.17 million, a PE ratio of -3.26 and a beta of 0.60. 111, Inc. Sponsored ADR has a fifty-two week low of $2.48 and a fifty-two week high of $11.17. The business has a 50 day moving average price of $5.88 and a 200-day moving average price of $5.66.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.